03:27 AM EST, 02/20/2025 (MT Newswires) -- Neil Kumar, Director, Chief Executive Officer, on February 16, 2025, sold 31,543 shares in BridgeBio Pharma ( BBIO ) for $1,140,024. Following the Form 4 filing with the SEC, Kumar has control over a total of 6,305,851 common shares of the company, with 211,718 shares held directly and 6,094,133 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000095017025023625/xslF345X05/ownership.xml